Relypsa Inc (NASDAQ:RLYP), a biopharmaceutical company announced that on December 1, 2015, the compensation committee of the company’s board of directors granted 65 …
CTI BioPharma Corp CTI BioPharma Corp (NASDAQ:CTIC) shares are tumbling 16.24% to $0.
In light of developments from the FDA, analysts remain bullish on both Relypsa Inc (NASDAQ:RLYP) and Sangamo Biosciences, Inc. (NASDAQ:SGMO).
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and biopharmaceutical company Relypsa Inc (NASDAQ:RLYP), following recent events. Valeant Pharmaceuticals …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and biopharmaceutical company Relypsa Inc (NASDAQ:RLYP), as both stocks …
Analysts came out today with an optimistic view on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Relypsa Inc (NASDAQ:RLYP), and Incyte Corporation (NASDAQ:INCY), as the iShares …
The long-awaited September meeting of the FOMC takes place this coming Thursday. Market participants are unusually attuned to this particular meeting due to …
